Cover Image
市場調查報告書

子宮內避孕器 (IUD) 的全球市場:2015-2019年

Global Intrauterine Devices Market 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 345174
出版日期 內容資訊 英文 66 Pages
訂單完成後即時交付
價格
Back to Top
子宮內避孕器 (IUD) 的全球市場:2015-2019年 Global Intrauterine Devices Market 2015-2019
出版日期: 2015年11月11日 內容資訊: 英文 66 Pages
簡介

子宮內避孕器 (IUD) 的市場從2014年到2019年以3.44%的年複合成長率成長

本報告提供全球子宮內避孕器 (IUD) 的市場相關調查、市場及產品概要、主要供應商的提供產品範例、美國的償付方案、市場整體及各類型的主要趨勢及收益規模的變化與預測、市場成長的各種影響因素分析、競爭環境與市場佔有率、主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 調查範圍

  • 市場概要
  • 主要供應商的提供產品

第3章 市場調查手法

  • 調查手法
  • 經濟指標

第4章 簡介

  • 焦點

第5章 關於子宮內避孕器

第6章 美國的償付方案

  • 主要IUD品牌供應商的折扣
  • LARC (長期作用型可逆的避孕) 的保險的費用負擔
  • 商業保險的LARC的費用負擔

第7章 市場形勢

  • 市場概要
  • 市場規模、預測
  • 波特的五力分析

第8章 市場分析:各產品類型

  • 荷爾蒙放出型
  • 銅離子放出型

第9章 地區分析

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第10章 市場成長的促進要素

第11章 市場推進因素的影響

第12章 市場課題

第13章 市場推進因素、課題的影響

第14章 市場趨勢

第15章 供應商環境

  • 各國的供應商的投資機會
  • 市場佔有率分析
  • 其他的有力供應商

第16章 主要供應商分析

  • Bayer HealthCare
  • Teva Pharmaceuticals
  • Actavis

第17章 附錄

第18章 關於Technavio

圖表

目錄
Product Code: IRTNTR7761

About Intrauterine devices

Intrauterine devices (IUDs) are contraceptive medical implants used to prevent pregnancies for a long period of time. They are also known as long-acting reversible contraceptive devices. An IUD is a T-shaped device, made of flexible plastic, with a copper wire wrapped around its stem, and is considered a safe and reliable method of sterilization for women. It is inserted into the uterus, and its primary aim is to prevent the fertilization of the egg by causing changes, such as thickening or toxicity of the cervical mucus, thus preventing fertilization by a sperm. There are two types of IUDs, namely, copper IUD (containing copper) and hormone-releasing IUDs (containing the progesterone hormone). Mirena and ParaGard are some of the prominent brands available in the market.

Technavio's analysts forecast the global intrauterine devices market to grow at a CAGR of 3.44% over the period 2014-2019.

Covered in this report

In this report, Technavio covers the present scenario and growth prospects of the global intrauterine devices market for 2015-2019. To calculate the market size, the report considers revenue generated from the sales of following type of products: Hormonal IUDs and copper IUDs.

Technavio's report, Global intrauterine devices market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report also presents the vendor landscape and a corresponding detailed analysis of the top three vendors in the market. Also, it discusses the major drivers and challenges in the market, as well as the key trends.

Key regions

  • Americas
  • APAC
  • EMEA

Key vendors

  • Actavis
  • Bayer
  • Teva Pharmaceutical

Other Prominent Vendors

  • Besins HealthCare
  • Brecuro Medical
  • Effik International
  • Eurogine
  • HLL Lifecare
  • HRA Pharma
  • Medisafe Distribution
  • OCON Medical
  • Pregna
  • SMB
  • Tespro
  • Trimedic Supply Network

Market driver

  • Long-term efficacy and increased acceptance of IUDs
  • For a full, detailed list, view our report

Market challenge

  • Lack of social acceptance
  • For a full, detailed list, view our report

Market trend

  • Increased institutional funding for IUDs
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: About intrauterine devices

PART 06: Reimbursement scenario in US

  • Purchase discounts by vendors for leading IUD brands
  • Medical coverage of LARC methods
  • Commercial insurance coverage LARC methods

PART 07: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 08: Market segmentation by product type

  • Hormonal intrauterine devices
  • Copper intrauterine devices

PART 09: Geographical segmentation

  • Intrauterine devices market in Americas
  • Intrauterine devices market in EMEA
  • Intrauterine devices market in APAC

PART 10: Market drivers

PART 11: Impact of drivers

PART 12: Market challenges

PART 13: Impact of drivers and challenges

PART 14: Market trends

PART 15: Vendor landscape

  • Vendor investment opportunities in different countries
  • Market share analysis 2014
  • Other prominent vendors

PART 16: Key vendor analysis

  • Bayer HealthCare
  • Teva Pharmaceuticals
  • Actavis

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Number of intrauterine device users in major countries
  • Exhibit 03: Different plans available for contraception methods
  • Exhibit 04: Global intrauterine devices market ($ billions)
  • Exhibit 05: Five forces analysis
  • Exhibit 06: Segmentation of global intrauterine devices market by product type
  • Exhibit 07: Segmentation of global intrauterine devices market by product type
  • Exhibit 08: Segmentation of global intrauterine devices market by geography 2014
  • Exhibit 09: Intrauterine devices market in Americas 2014-2019 ($ billions)
  • Exhibit 10: Intrauterine device prevalence rate in North America in 2013
  • Exhibit 11: Intrauterine device prevalence rate in South America in 2013
  • Exhibit 12: Intrauterine devices market in EMEA 2014-2019 ($ billions)
  • Exhibit 13: Intrauterine device prevalence rate in EMEA in 2013
  • Exhibit 14: Intrauterine devices market in APAC 2014-2019 ($ billions)
  • Exhibit 15: Intrauterine device prevalence rate in APAC in 2013
  • Exhibit 16: Segmentation of global intrauterine devices market by geography 2014-2019 ($ millions)
  • Exhibit 17: Segmentation of global intrauterine devices market by geography 2014-2019 (%)
  • Exhibit 18: Effectiveness of female contraception by types
  • Exhibit 19: Classification of modern IUDs
  • Exhibit 20: Percentage of couples using modern method of contraception (IUD)
  • Exhibit 21: Impact of drivers
  • Exhibit 22: Impact of drivers and challenges
  • Exhibit 23: Unintended pregnancies by region (%)
  • Exhibit 24: Actavis: Key takeaways
  • Exhibit 25: Bayer: Key takeaways
  • Exhibit 26: Teva Pharmaceutical: Key takeaways
  • Exhibit 27: Bayer HealthCare: Business segmentation by revenue 2014
  • Exhibit 28: Bayer HealthCare: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 29: Bayer HealthCare: Geographical segmentation by revenue 2014
  • Exhibit 30: Teva Pharmaceuticals: Business segmentation by revenue 2014
  • Exhibit 31: Teva Pharmaceuticals: Business segmentation by revenue 2013 and 2014
  • Exhibit 32: Teva Pharmaceuticals: Geographical segmentation by revenue 2014
  • Exhibit 33: Actavis: Business segmentation by revenue 2014
  • Exhibit 34: Actavis: Business segmentation by revenue 2013 and 2014
Back to Top